Spectranetics Corp (SPNC) Reports In-Line Q1 EPS

Spectranetics Corp (NASDAQ: SPNC) reported Q1 EPS of ($0.14), in-line with the analyst estimate of ($0.14). Revenue for the quarter came in at $39.6 million versus the consensus estimate of $39.6 million.

Spectranetics Corp sees FY2014 EPS of ($0.18)-($0.23), versus the consensus of ($0.21). Spectranetics Corp sees FY2014 revenue of $171.5-174.0 million, versus the consensus of $173.9 million. Adjusted EBITDA is anticipated to be in the range of $3.5 - $5.5 million, compared with Adjusted EBITDA of $11.2 million in 2013. The medical device tax is included in both periods.

For earnings history and earnings-related data on Spectranetics Corp (SPNC) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• CorMedix (CRMD) Tops Q2 EPS by 6c; Offers Guidance
• Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c